COVID-19

Sales of Ubiquinol Soar Globally Post Pandemic

Post Pandemic, Ubiquinol Sales Continue to Rise

By now, most people have had COVID-19, but many people are still struggling with the side-effects long after the initial infection has passed.  

It is believed five to 10 per cent of Australians are experiencing the impacts of long-COVID, with an increased risk of a range of chronic outcomes, including cardiovascular disease, metabolic disorders, and mental and neurological complaints up to 12 months following infection.[1] 

Recent research suggests that COVID-19 infection is associated with future cardiovascular events. A new study on 66 people hospitalised with severe COVID-19 showed permanent changes in cholesterol composition three months after recovery, indicating that COVID-19 can induce long-term disturbances in lipoprotein metabolism and increase the risk of developing heart disease later in life.[2] 

Following a study published in Frontiers,[3] that found ubiquinol supplementation played a role in accelerating the recovery of mitochondrial health in patients with post COVID-19, NutraIngredients Asia[4] reported a growth in demand for supplementations, including ubiquinol.  

As leading health experts and research continues to acknowledge the role of integrative health strategies, including the role of supplementations to improve areas of deficiencies, consumers globally have taken greater interest in preventative measures to improve overall health outcomes.  

For more information about mitochondrial health and the impact of ubiquinol, also have a look at our post for sponsorship of the ACNEM Long COVID conference 

References:
[1]
https://www.aihw.gov.au/reports/covid-19/long-covid-in-australia-a-review-of-the-literature/summary
[2] Ueland T, et al. Low-density lipoprotein particles carrying proinflammatory proteins with altered aggregation pattern detected in COVID-19 patients 3 months after hospitalization. J Infect 2023;86(5):489-492, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941305/pdf/main.pdf
[3] Sumbalová Z, et al. Reduced platelet mitochondrial respiration and oxidative phosphorylation in patients with post COVID-19 syndrome are regenerated after spa rehabilitation and targeted ubiquinol therapy. Frontiers in Molecular Biosciences 2022;9: 10.3389/fmolb.2022.1016352
[4] https://www.nutraingredients-asia.com/Article/2023/01/25/co-enzyme-q10-in-high-demand-as-covid-19-cases-grow-in-china   

ubiquinol

Recent Posts

Upcoming Pharmacist Webinar with Dr Ross Walker

A Pharmacist’s Guide to Ubiquinol’s Impact on Cardiovascular Health and Healthy Ageing   If you’re a…

1 week ago

Natural Health Product Innovation Expo 2024

Kaneka Ubiquinol™ in New Zealand for Industry Innovation The Kaneka team was proud to attend…

2 weeks ago

Mitochondrial Health and Ubiquinol Offer New Hope for Male Fertility

How Ubiquinol Can Assist Startling Global Decline in Fertility Rates Male fertility rates have declined sharply…

3 weeks ago

Ubiquinol: The Overlooked Nutrient for Vegans and Vegetarians

Ubiquinol Deficiency in Plant-Based Diets A 2022 study published by Nutrafoods revealed that vegans and…

4 weeks ago

Investigating the Application of Ubiquinol in Mitochondrial Function

Research Insights into Mitochondrial Function, Key Biomarkers, and the Role of Ubiquinol   Optimising mitochondrial function…

1 month ago

Kaneka Ubiquinol™ at VitaFoods Asia 2024, Bangkok

Proud Winner of the prestigious NutraIngredients Asia Healthy Ageing Product of the Year Award 2024…

2 months ago